Amnis Corporation and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
SEATTLE, May 7 /PRNewswire/ -- Amnis Corporation and Gene Company, Ltd. announced today the completion of an agreement under which Gene Company will sell and service the Amnis ImageStream(R) system in China. Effective immediately, the scientific research communities in Hong Kong, Shanghai, Beijing and Guangzhou now have access to this important cell analysis technology.
"We are extremely pleased to have begun what we expect will be a valuable partnership with Gene Company. We are looking forward to working with them to expand the commercial presence of the ImageStream in China," said David Basiji, Ph.D., Amnis' President and CEO. "Gene Company has a strong presence in the major Chinese scientific markets and brings a distinguished history as a supplier to the partnership. We are quite confident that they will represent the ImageStream extremely well."
Dr. Cheung To, Chairman of Gene Company, added, "We envisage that distribution of the Amnis ImageStream system will remarkably empower pioneering labs with next generation microscopy and flow cytometry in a single platform to advance applications in drug discovery, molecular and cellular research and diagnostics in China. Gene Company has high confidence in Amnis and looks forward to a synergetic cooperation."
About Amnis:
Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets the ImageStream system for high speed imaging of cells in flow. The system generates six high resolution microscopic images of cells as they flow through the instrument at rates up to 300 cells per second. The system is unique in its ability to image tens of thousands of cells in minutes without the need to make slides. The IDEAS(R) image analysis package, an integral part of the ImageStream system, is a highly sophisticated yet easy to use tool for processing hundreds of thousands of images at a time. IDEAS enables highly advanced research applications in hematology, immunology, oncology and provides a critical foundation for the company's clinical applications development.
About Gene Company:
Gene Company Limited (Gene Company) incorporated in 1992 and headquartered in Hong Kong, has established presences in 20 major cities in P.R. China. Over the years of development, Gene Company is regarded as one of the largest distribution network in China and established a solid and highly loyal customer base, constituting renowned research institutes, hospitals, and pharmaceutical and biotech companies. Gene Company has also successfully become one of the major research product suppliers to key genomics, proteomics, biochip and stem cell research centres. More information about Gene Company is obtainable from their home page: http://www.genehk.com.
CONTACT: David A Basiji of Amnis Corporation, +1-206-374-7165,
dbasiji@amnis.com
Web site: http://www.amnis.com/
http://www.genehk.com/